世界の駆虫薬産業:成長傾向・競合分析

QYResearchが発行した調査報告書(DATA909X00126)
◆英語タイトル:Global Anthelmintic Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
◆商品コード:DATA909X00126
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月22日(※2024年版があります。お問い合わせください)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界の駆虫薬市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。駆虫薬の種類別には、経口薬、注射剤に、用途別には、人間用、動物用に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・駆虫薬の種類別市場規模:経口薬、注射剤
・駆虫薬の用途別市場規模:人間用、動物用
・駆虫薬の地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Novartis、Pfizer、Bayer、Cipla、Sun Pharmaceutical Industries、Mankind Pharma、Johnson & Johnson、Merck
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling).In 2018, the global Anthelmintic Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anthelmintic Drugs.

This study researches the market size of Anthelmintic Drugs, presents the global Anthelmintic Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Anthelmintic Drugs in key regions like North America, Europe and Asia-Pacific, presents sales, revenue, market share, growth rate of Anthelmintic Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
Merck

Market Segment by Product Type
Oral Drugs
Injectables

Market Segment by Application
For Human
For Animal

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Anthelmintic Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anthelmintic Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anthelmintic Drugs are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anthelmintic Drugs Market Size Growth Rate by Type
1.3.2 Oral Drugs
1.3.3 Injectables
1.4 Market Segment by Application
1.4.1 Global Anthelmintic Drugs Market Share by Application (2019-2025)
1.4.2 For Human
1.4.3 For Animal
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Anthelmintic Drugs Market Size
2.1.1 Global Anthelmintic Drugs Revenue 2014-2025
2.1.2 Global Anthelmintic Drugs Sales 2014-2025
2.2 Anthelmintic Drugs Growth Rate by Regions
2.2.1 Global Anthelmintic Drugs Sales by Regions 2014-2019
2.2.2 Global Anthelmintic Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Anthelmintic Drugs Sales by Manufacturers
3.1.1 Anthelmintic Drugs Sales by Manufacturers 2014-2019
3.1.2 Anthelmintic Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anthelmintic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Anthelmintic Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Anthelmintic Drugs Price by Manufacturers
3.4 Key Manufacturers Anthelmintic Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anthelmintic Drugs Market
3.6 Key Manufacturers Anthelmintic Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Drugs Sales and Revenue (2014-2019)
4.1.2 Injectables Sales and Revenue (2014-2019)
4.2 Global Anthelmintic Drugs Sales Market Share by Type
4.3 Global Anthelmintic Drugs Revenue Market Share by Type
4.4 Anthelmintic Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Anthelmintic Drugs Sales by Application

6 North America
6.1 North America Anthelmintic Drugs Breakdown Data by Company
6.2 North America Anthelmintic Drugs Breakdown Data by Type
6.3 North America Anthelmintic Drugs Breakdown Data by Application
6.4 North America Anthelmintic Drugs Breakdown Data by Countries
6.4.1 North America Anthelmintic Drugs Sales by Countries
6.4.2 North America Anthelmintic Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Anthelmintic Drugs Breakdown Data by Company
7.2 Europe Anthelmintic Drugs Breakdown Data by Type
7.3 Europe Anthelmintic Drugs Breakdown Data by Application
7.4 Europe Anthelmintic Drugs Breakdown Data by Countries
7.4.1 Europe Anthelmintic Drugs Sales by Countries
7.4.2 Europe Anthelmintic Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anthelmintic Drugs Breakdown Data by Company
8.2 Asia Pacific Anthelmintic Drugs Breakdown Data by Type
8.3 Asia Pacific Anthelmintic Drugs Breakdown Data by Application
8.4 Asia Pacific Anthelmintic Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Anthelmintic Drugs Sales by Countries
8.4.2 Asia Pacific Anthelmintic Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Anthelmintic Drugs Breakdown Data by Company
9.2 Central & South America Anthelmintic Drugs Breakdown Data by Type
9.3 Central & South America Anthelmintic Drugs Breakdown Data by Application
9.4 Central & South America Anthelmintic Drugs Breakdown Data by Countries
9.4.1 Central & South America Anthelmintic Drugs Sales by Countries
9.4.2 Central & South America Anthelmintic Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Anthelmintic Drugs Breakdown Data by Type
10.2 Middle East and Africa Anthelmintic Drugs Breakdown Data by Application
10.3 Middle East and Africa Anthelmintic Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Anthelmintic Drugs Sales by Countries
10.3.2 Middle East and Africa Anthelmintic Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.1.4 Anthelmintic Drugs Product Introduction
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.2.4 Anthelmintic Drugs Product Introduction
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.3.4 Anthelmintic Drugs Product Introduction
11.3.5 Bayer Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.4.4 Anthelmintic Drugs Product Introduction
11.4.5 Cipla Recent Development
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.5.4 Anthelmintic Drugs Product Introduction
11.5.5 Sun Pharmaceutical Industries Recent Development
11.6 Mankind Pharma
11.6.1 Mankind Pharma Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.6.4 Anthelmintic Drugs Product Introduction
11.6.5 Mankind Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.7.4 Anthelmintic Drugs Product Introduction
11.7.5 Johnson & Johnson Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Anthelmintic Drugs
11.8.4 Anthelmintic Drugs Product Introduction
11.8.5 Merck Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anthelmintic Drugs Sales Channels
12.2.2 Anthelmintic Drugs Distributors
12.3 Anthelmintic Drugs Customers

13 Market Forecast
13.1 Global Anthelmintic Drugs Sales and Revenue Forecast 2019-2025
13.2 Global Anthelmintic Drugs Sales Forecast by Type
13.3 Global Anthelmintic Drugs Sales Forecast by Application
13.4 Anthelmintic Drugs Forecast by Regions
13.4.1 Global Anthelmintic Drugs Sales Forecast by Regions 2019-2025
13.4.2 Global Anthelmintic Drugs Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Anthelmintic Drugs Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Anthelmintic Drugs Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Anthelmintic Drugs Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Anthelmintic Drugs Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Anthelmintic Drugs Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Anthelmintic Drugs Product Picture
Table Anthelmintic Drugs Key Market Segments
Table Major Manufacturers Anthelmintic Drugs Covered in This Report
Table Global Anthelmintic Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Anthelmintic Drugs Sales Market Shar by Type 2014-2025
Figure Oral Drugs Figures
Table Major Manufacturers of Oral Drugs
Figure Injectables Figures
Table Major Manufacturers of Injectables
Table Global Anthelmintic Drugs Market Share by Application 2019-2025 (K Units)
Figure For Human Use Case
Figure For Animal Use Case
Figure Anthelmintic Drugs Report Years Considered
Figure Global Anthelmintic Drugs Market Size 2014-2025 (Million US$)
Figure Global Anthelmintic Drugs Sales 2014-2019 (K Units)
Table Global Anthelmintic Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Anthelmintic Drugs Sales by Regions 2014-2019 (K Units)
Table Global Anthelmintic Drugs Sales Market Share by Regions 2014-2019
Figure Global Anthelmintic Drugs Sales Market Share by Regions 2014-2019
Figure Global Anthelmintic Drugs Sales Market Share by Regions in 2018
Table Global Anthelmintic Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Anthelmintic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Anthelmintic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Anthelmintic Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Anthelmintic Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Anthelmintic Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Anthelmintic Drugs Sales Share by Manufacturers in 2018
Table Anthelmintic Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Anthelmintic Drugs Revenue Share by Manufacturers (2014-2019)
Figure Anthelmintic Drugs Value Share by Manufacturers in 2018
Table Global Anthelmintic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Anthelmintic Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Anthelmintic Drugs Plants/Factories Distribution
Table Key Manufacturers Anthelmintic Drugs Area Served
Table Date of Key Manufacturers Enter into Anthelmintic Drugs Market
Table Key Manufacturers Anthelmintic Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Oral Drugs Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Injectables Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Anthelmintic Drugs Sales by Type (2014-2019) (K Units)
Table Global Anthelmintic Drugs Sales Share by Type (2014-2019)
Figure Global Anthelmintic Drugs Sales Market Share by Type (2014-2019)
Figure Global Anthelmintic Drugs Sales Market Share by Type in 2018
Table Global Anthelmintic Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Anthelmintic Drugs Revenue Share by Type (2014-2019)
Figure Global Anthelmintic Drugs Revenue Market Share by Type (2014-2019)
Figure Global Anthelmintic Drugs Revenue Market Share by Type in 2018
Table Anthelmintic Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Anthelmintic Drugs Sales by Application (2014-2019) (K Units)
Table Global Anthelmintic Drugs Sales Share by Application (2014-2019)
Figure Global Sales Anthelmintic Drugs Market Share by Application (2014-2019)
Figure Global Sales Anthelmintic Drugs Market Share by Application in 2018
Figure North America Anthelmintic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Anthelmintic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anthelmintic Drugs Sales by Company (2014-2019) (K Units)
Table North America Anthelmintic Drugs Sales Market Share by Company (2014-2019)
Figure North America Anthelmintic Drugs Sales Market Share by Company in 2018
Table North America Anthelmintic Drugs Sales by Type (2014-2019) (K Units)
Table North America Anthelmintic Drugs Sales Market Share by Type (2014-2019)
Figure North America Anthelmintic Drugs Market Share by Type in 2018
Table North America Anthelmintic Drugs Sales by Application (2014-2019) (K Units)
Table North America Anthelmintic Drugs Sales Market Share by Application (2014-2019)
Figure North America Anthelmintic Drugs Market Share by Application in 2018
Table North America Anthelmintic Drugs Sales by Countries (2014-2019) (K Units)
Table North America Anthelmintic Drugs Sales Market Share by Countries (2014-2019)
Figure North America Anthelmintic Drugs Sales Market Share by Countries in 2018
Table North America Anthelmintic Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Anthelmintic Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Anthelmintic Drugs Revenue Market Share by Countries in 2018
Figure United States Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Europe Anthelmintic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Anthelmintic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anthelmintic Drugs Sales by Company (2014-2019) (K Units)
Table Europe Anthelmintic Drugs Sales Market Share by Company (2014-2019)
Figure Europe Anthelmintic Drugs Sales Market Share by Company in 2018
Table Europe Anthelmintic Drugs Sales by Type (2014-2019) (K Units)
Table Europe Anthelmintic Drugs Sales Market Share by Type (2014-2019)
Figure Europe Anthelmintic Drugs Sales Market Share by Type in 2018
Table Europe Anthelmintic Drugs Sales by Application (2014-2019) (K Units)
Table Europe Anthelmintic Drugs Sales Market Share by Application (2014-2019)
Figure Europe Anthelmintic Drugs Sales Market Share by Application in 2018
Table Europe Anthelmintic Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Anthelmintic Drugs Sales Market Share by Countries (2014-2019)
Figure Europe Anthelmintic Drugs Sales Market Share by Countries in 2018
Table Europe Anthelmintic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Anthelmintic Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Anthelmintic Drugs Revenue Market Share by Countries in 2018
Figure Germany Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Anthelmintic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Anthelmintic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anthelmintic Drugs Sales by Regions (2014-2019) (K Units)
Table Asia Pacific Anthelmintic Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Anthelmintic Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Anthelmintic Drugs Sales by Type (2014-2019) (K Units)
Table Asia Pacific Anthelmintic Drugs Sales Market Share by Type (2014-2019)
Figure Asia Pacific Anthelmintic Drugs Market Share by Type in 2018
Table Asia Pacific Anthelmintic Drugs Sales by Application (2014-2019) (K Units)
Table Asia Pacific Anthelmintic Drugs Sales Market Share by Application (2014-2019)
Figure Asia Pacific Anthelmintic Drugs Market Share by Application in 2018
Table Asia Pacific Anthelmintic Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Anthelmintic Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Anthelmintic Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Anthelmintic Drugs Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Anthelmintic Drugs Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Anthelmintic Drugs Revenue Market Share by Regions in 2018
Figure China Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Anthelmintic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Anthelmintic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Anthelmintic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anthelmintic Drugs Sales by Company (2014-2019) (K Units)
Table Central & South America Anthelmintic Drugs Sales Market Share by Company (2014-2019)
Figure Central & South America Anthelmintic Drugs Sales Market Share by Company in 2018
Table Central & South America Anthelmintic Drugs Sales by Type (2014-2019) (K Units)
Table Central & South America Anthelmintic Drugs Sales Market Share by Type (2014-2019)
Figure Central & South America Anthelmintic Drugs Market Share by Type in 2018
Table Central & South America Anthelmintic Drugs Sales by Application (2014-2019) (K Units)
Table Central & South America Anthelmintic Drugs Sales Market Share by Application (2014-2019)
Figure Central & South America Anthelmintic Drugs Market Share by Application in 2018
Table Central & South America Anthelmintic Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Anthelmintic Drugs Sales Market Share by Countries (2014-2019)
Figure Central & South America Anthelmintic Drugs Sales Market Share by Countries in 2018
Table Central & South America Anthelmintic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anthelmintic Drugs Revenue Market Share by Countries (2014-2019)
Figure Central & South America Anthelmintic Drugs Revenue Market Share by Countries in 2018
Figure Brazil Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Anthelmintic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Anthelmintic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Anthelmintic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anthelmintic Drugs Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Anthelmintic Drugs Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Anthelmintic Drugs Sales Market Share by Type in 2018
Table Middle East and Africa Anthelmintic Drugs Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Anthelmintic Drugs Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Anthelmintic Drugs Sales Market Share by Application in 2018
Table Middle East and Africa Anthelmintic Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Anthelmintic Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Anthelmintic Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Anthelmintic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anthelmintic Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anthelmintic Drugs Revenue Market Share by Countries in 2018
Figure GCC Countries Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Anthelmintic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Anthelmintic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa Anthelmintic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Anthelmintic Drugs Revenue Growth Rate (2014-2019) (K Units)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Novartis Anthelmintic Drugs Sales Market Share in Global Market
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Pfizer Anthelmintic Drugs Sales Market Share in Global Market
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Bayer Anthelmintic Drugs Sales Market Share in Global Market
Table Bayer Recent Development
Table Cipla Company Details
Table Cipla Description and Business Overview
Table Cipla Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cipla Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Cipla Anthelmintic Drugs Sales Market Share in Global Market
Table Cipla Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Description and Business Overview
Table Sun Pharmaceutical Industries Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Sun Pharmaceutical Industries Anthelmintic Drugs Sales Market Share in Global Market
Table Sun Pharmaceutical Industries Recent Development
Table Mankind Pharma Company Details
Table Mankind Pharma Description and Business Overview
Table Mankind Pharma Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mankind Pharma Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Mankind Pharma Anthelmintic Drugs Sales Market Share in Global Market
Table Mankind Pharma Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Johnson & Johnson Anthelmintic Drugs Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Anthelmintic Drugs Sales Growth Rate (2014-2019)
Table Merck Anthelmintic Drugs Sales Market Share in Global Market
Table Merck Recent Development
Figure Anthelmintic Drugs Value Chain
Table Anthelmintic Drugs Distributors List
Table Anthelmintic Drugs Customers List
Table Global Anthelmintic Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Anthelmintic Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Anthelmintic Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Anthelmintic Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Anthelmintic Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Anthelmintic Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Anthelmintic Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Anthelmintic Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Anthelmintic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Anthelmintic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Anthelmintic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Anthelmintic Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Anthelmintic Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Anthelmintic Drugs Revenue Market Share Forecast by Regions 2019-2025
Table North America Anthelmintic Drugs Sales Forecast by Countries 2019-2025 (K Units)
Table North America Anthelmintic Drugs Sales Market Share Forecast by Countries 2019-2025
Table North America Anthelmintic Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Anthelmintic Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure United States Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Canada Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Mexico Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Table Europe Anthelmintic Drugs Sales Forecast by Countries 2019-2025 (K Units)
Table Europe Anthelmintic Drugs Sales Market Share Forecast by Countries 2019-2025
Table Europe Anthelmintic Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Anthelmintic Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure France Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure UK Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Italy Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Russia Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Table Asia Pacific Anthelmintic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific Anthelmintic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Anthelmintic Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Anthelmintic Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure China Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure South Korea Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure India Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Australia Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Indonesia Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Thailand Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Malaysia Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Philippines Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Vietnam Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Table Central & South America Anthelmintic Drugs Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America Anthelmintic Drugs Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Anthelmintic Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Anthelmintic Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa Anthelmintic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa Anthelmintic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Anthelmintic Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Anthelmintic Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure GCC Countries Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure Egypt Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Figure South Africa Anthelmintic Drugs Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Novartis、Pfizer、Bayer、Cipla、Sun Pharmaceutical Industries、Mankind Pharma、Johnson & Johnson、Merck

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の駆虫薬産業:成長傾向・競合分析(Global Anthelmintic Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025)]についてメールでお問い合わせはこちらでお願いします。